Key Points
-
The review examines the current state of knowledge concerning the regulation of the cell cycle in the CNS during development and in the adult. Several key points emerge from the assembled evidence.
-
Neurons must constantly suppress the cell cycle once they complete neurogenesis. If they fail to do so they will re-enter a cell cycle that they will not be able to complete.
-
These 'cycling' neurons seem to be consigned to one of two fates depending on their stage of maturation: in young differentiating neurons, re-entry into a cell cycle leads to death within hours, which can be blocked by inhibition of the cell cycle. In adult neurons, re-entry into a cell cycle leads to the expression of cell cycle proteins and replication of some or all of the genome, but for many months the neurons appear incapable of either completing the cycle or dying.
-
The linkage between cell cycle and cell death appears to lie at the root of many human neurodegenerative diseases.
-
The neuron uses a multi-tiered strategy to suppress the cell cycle: there is strong evidence for genomic rearrangements, cell cycle proteins are found in unexpected locations and proteins switch from functioning as cell cycle promoters to acting as cell cycle suppressors.
-
Many proteins originally identified for their role in cell cycle progression seem to perform essential functions in the neuronal cytoplasm and, in particular, at the synapse.
Abstract
Adult CNS neurons are typically described as permanently postmitotic but there is probably nothing permanent about the neuronal cell cycle arrest. Rather, it appears that these highly differentiated cells must constantly keep their cell cycle in check. Relaxation of this vigilance leads to the initiation of a cell cycle and entrance into an altered and vulnerable state, often leading to death. There is evidence that neurons which are at risk of neurodegeneration are also at risk of re-initiating a cell cycle process that involves the expression of cell cycle proteins and DNA replication. Failure of cell cycle regulation might be a root cause of several neurodegenerative disorders and a final common pathway for others.
Similar content being viewed by others
Main
Most neuroscientists are comfortable with the axiom that CNS neurons are 'permanently postmitotic'. The intricate cascades of kinases and transcription factors that regulate the cell cycle in a HeLa or lymphocytic cell line (Box 1) seem removed from the day-to-day biochemistry of an adult neuron. Indeed, for decades developmental neurobiologists have shown that the bulk of CNS neurogenesis takes place in a tightly packed layer of nuclei lining the lumen of the neural tube (the ventricular zone, VZ) and later in the closely apposed region known as the subventricular zone (SVZ). Patches of adult neural stem cells can be found lining the lateral ventricles — to various degrees in different vertebrates — but these cells represent the persistence of a mitotic progenitor population rather than the division of a fully differentiated adult nerve cell. Indeed, the concept of a neuronal birthday carries with it the inescapable conclusion that once a neuron leaves the VZ (or SVZ) it will never divide again.
The absence of cell division is believed to be a core feature of neuronal identity. The depth of this belief is such that, on the face of it, cell cycle regulation in the adult neuron hardly seems to be a problem at all — instead, it seems to be more of an oxymoron. This review aims to stimulate the idea that cell cycle regulation is actually a constant problem for mature neurons. We summarize an increasing body of evidence which illustrates that, far from being permanently postmitotic, adult neurons must continuously hold their cell cycle in check. This perspective stems from the finding that cell cycle control can fail in 'postmitotic' neurons. The price of failure is high and the death of neurons in many diseases may be an inexorable consequence of the re-initiation of the cell cycle in an adult neuron.
The neuronal cell cycle
The CNS begins as a microscopic sheet of a few hundred ectodermal cells (the neural plate) but rapidly develops into a macroscopic structure with as many as a hundred billion neurons in the adult human. This enormous expansion in cell number means that the proper development of the brain depends on a well-regulated pattern of cell division. This raises two questions: what molecular switches regulate the rate and number of cell divisions during growth of the nervous system, and how does the mature postmitotic neuron regulate the cell cycle machinery so that it can refrain from division for many years?
The kinetics of neurogenesis in the neural tube have been studied most carefully in the mouse neocortex. Here, each neuronal lineage apparently undergoes 11 divisions before ceasing neuron production1,2,3,4,5. The VZ itself seems to be highly stratified. Mitosis and cytokinesis occur at the ventricular surface, whereas other cell cycle activities, including DNA synthesis, occur at some distance from the ventricle (Fig. 1). The proposed stratification of cell cycle phases is validated by the finding that the DNA precursors 3H-thymidine6,7 or 5-bromo-2′-deoxyuridine8 (BrdU, a thymidine analogue) label cells mainly in the superficial regions of the VZ when injected shortly before the animal is killed (Fig. 1). A secondary germinative zone, the SVZ, develops later just beyond the VZ. The functional differences between the ventricular and subventricular proliferative regions are not entirely clear. Both are regions in which neurons undergo their final cell division (or birthday). Furthermore, each region generates neurons as well as glia, yet there seem to be many molecular and cytological differences between the two regions9,10. By the end of the developmental period, the VZ has been depleted of all mitotic cells whereas the SVZ persists (to a greater or lesser extent in different vertebrates) at the lumen of the lateral ventricles and harbours stem cell precursor populations that give rise to neurons in the adult. The kinetics and function of these adult-generated cells is hotly debated11,12,13,14. However, because they are generated by stem cells and not from the division of cells that are already part of the adult neuronal circuitry, they do not contravene the basic tenet of our review: a mature, differentiated nerve cell does not divide.
The molecular signals that stimulate cell division during neurogenesis are not entirely known, but there is evidence that sonic hedgehog (SHH) signals from certain cell layers to stimulate mitotic activity in both the VZ and in a specialized germinal region of the cerebellum known as the external granule cell layer. The actions of SHH are complex; it functions in patterning, cell fate determination and survival as well as proliferation. SHH seems to regulate cell division directly, via the transcription factors GLI and N-MYC15 (for a fuller discussion, see Ref. 16). The mechanism by which the period of neuronal cell division in the VZ or SVZ is brought to an end is equally uncertain. Inherent in the above description is the conclusion that every neuron has a birthday — a last time in embryogenesis at which 3H-thymidine or BrdU will label its genomic DNA. This final cell division signals the beginning of maturation, but also marks the point at which the nerve cell must put in place the mechanisms that will ensure a permanent mitotic arrest. Despite the importance of these mechanisms, virtually nothing is known about them. The tumour suppressor retinoblastoma (RB) seems to be crucial, as null alleles of this gene cause neurons to die after re-entering a cell cycle17,18,19,20. Cyclin-dependent kinase inhibitors (CKIs) also seem to be involved in cell cycle arrest, as the loss of CKI family members results in alterations in cell cycle kinetics21. Studies in the retina and other tissues indicate that two subclasses of CKIs — the Ink4 class (including p16Ink4a, p15Ink4b, p18Ink4c and p19Ink4d) and the Cip/Kip class (including p21Cip1, p27Kip1 and p57Kip2) — work coordinately to ensure cell cycle exit22, although neither class is necessary or sufficient to do so.
Loose ends. There is surprisingly little information that links the biochemical and molecular description of the cell cycle with the largely cytological description of neurogenesis and migration. Cell cycle proteins are found in brain lysates at early developmental stages21; however, there are few immunocytochemical studies of these proteins23,24. The model shown in Fig. 1 predicts that the nuclei of the VZ are stratified by cell cycle phase, and therefore that cell cycle proteins should be expressed in layers. Indeed, the M phase marker phosphohistone H3 is found in mitotic cells at the ventricular surface and BrdU, which labels cells in S phase, labels cells in the expected regions of the upper VZ20,25. Most other cell cycle proteins are not so neatly distributed. For example, proliferating cell nuclear antigen (PCNA), another S phase marker25, and cyclin E, a late G1 phase marker26, appear in cells in all strata of the VZ. For the CKIs, the picture is just as complicated22. Cyclins and cyclin-dependent kinases (CDKs) are regulated by many factors that control their synthesis, degradation and localization. Their broad distribution in the VZ indicates that either the predicted stratification of cell cycle phase is incorrect or that the regulation of these proteins in dividing neuronal precursors differs from the simple models described in most textbooks.
Another unexpected finding is that DNA repair enzymes are active immediately after the completion of neurogenesis. Mutations in genes involved in DNA double-strand break (DSB) repair, including Xrcc427, ligase IV (Ref. 28) and the DNA repair polymerase, Polβ 29,30, result in embryonic lethal phenotypes. Moreover, neuronal death in ligase IV knockouts can be suppressed by the introduction of a second mutation in ataxia telangiectasia mutated (Atm)31, an early component of the DSB detection and response system. The implication of these findings is that DSBs are normal events in early neuronal differentiation. The function of these proposed breaks is unknown32,33,34, but the correlation of human CNS disorders with defects in DSB repair genes underscores their importance in the development of the brain35,36.
While we might predict that the mutation of cell cycle proteins would have devastating effects on development and neurogenesis, a final loose end comes from the observation that homozygous null embryos for virtually every one of the CDKs, cyclins and CKIs (including CDK2, CDK4 and CDK6, as well as cyclins A1, B2, D1, D2, D3, E1 and E2) survive most or all of the way through neurogenesis (Table 1). The only exception to this rule are embryos lacking cyclin A2 (Ref. 37) or cyclin B1 (Ref. 38) (the knockout of CDK1 has not been reported). The survival of these mice may be due to functional redundancy, as mice with mutations in two or three of these proteins die earlier. However, even the cyclin D triple mutant (Ccnd1−/−;Ccnd2−/−;Ccnd3−/−) progresses to approximately embryonic day 16.5 (Ref. 39), which is after most neurogenesis has occurred, suggesting that there is more to neuronal cell cycle regulation than cyclins and CDKs alone. Similarly, RB-deficient embryos die in the third trimester, but a normally patterned brain and spinal cord develop17,18,19. Finally, the loss of the CKI p27Kip1 or p19Ink4d alters cell cycle kinetics during neurogenesis40,41, and the balance of different cell types that differentiate can be affected, but cell division eventually stops. Indeed, the lasting morphological changes observed in these mice are relatively subtle, given the predicted role of these proteins in orchestrating neuronal exit from the cell cycle (for a fuller description of such mutations in the context of the entire developmental process, see Ref. 42). A tentative summary of how these gene products affect the three major phases of CNS neuronal development is outlined in Fig. 2.
Failure of cell cycle arrest in development
As described above, CNS neurons do not divide after they emigrate from the VZ or SVZ. What would happen if a neuron lost control of its cell cycle and re-entered cell division? Although it seems paradoxical, evidence suggests that the neuron would probably die. We refer to this process as cycle-related neuronal death (CRND) — a purposefully cautious term (see below).
The first experimental evidence for CRND came from two independent lines of experimentation in which RB protein was inactivated by the large transformation (T) antigen of the SV40 virus. Inactivation of RB leads to the release of the transcription factor E2F1 and the subsequent upregulation of many cell cycle genes. When T antigen is introduced into most cultured cells, they are released from normal proliferation control and become transformed. However, when T antigen is introduced into postmitotic neurons, they degenerate43,44,45,46. Cell division begins and BrdU is incorporated into DNA, but M phase is not initiated and the neuron dies shortly after44. As might be predicted, this process is E2F1-dependent47.
There is also massive apoptotic neuronal death in mice with homozygous null alleles of Rb17,18,19. In these animals, CRND occurs after the migrating neuroblasts leave the ventricular region. BrdU injections a few hours before sacrifice have revealed that neurons in normally postmitotic regions of the maturing brain and spinal cord are engaged in ectopic DNA synthesis17,18,19. Most of the neuronal death in Rb knockouts is dependent on both E2F1 and another transcription factor, p53 (Ref. 48, 49). Detailed examination of the mutant embryos has revealed a second, less appreciated phenotype: before their death, neurons are both morphologically and biochemically immature, suggesting that RB is also required for neuronal differentiation20.
This link between cell cycle suppression and final neuronal differentiation is found for many cell cycle genes, and seems to work both ways. Early investigations that explored the death response of cultured sympathetic neurons after withdrawal of nerve growth factor (NGF) revealed an unexpected increase in the levels of cyclin D mRNA50. This indicated that loss of trophic support during development might lead to cell cycle initiation as part of the death process. Research on models of target-related cell death in the mouse cerebellum51 has revealed that neuronal death is preceded by re-expression of cell cycle markers and DNA synthesis in vivo. These correlations are strong evidence that a neuron must regulate its cell cycle or risk death during postmitotic maturation.
The use of in vitro models of CRND has been invaluable for establishing the causative nature of cell cycle induction in the process of cell death. Drugs that block cell cycle advance can prevent the death of both PC12 cells and sympathetic neurons after either NGF withdrawal or DNA damage52,53,54,55,56. Similarly, various insults including trophic factor withdrawal, excitotoxicity and toxic concentrations of amyloid-β can drive a lethal cell cycle in cultured CNS neurons and, critically, blocking the cell cycle can prevent neuronal death57,58,59,60. In sympathetic neurons, trophic factor withdrawal or DNA damage leads to an E2F1-dependent upregulation of B-myb and C-myb (transcription factors that are believed to have a role in S phase progression)61. This results in the expression of BIM (a BCL2 homology three domain-only molecule)62, which in turn leads to cell death. In activity-deprived cerebellar granule cells, phosphorylation of the proapoptotic molecule BAD by CDK1 appears to have a similar role63,64.
Thus, both in vivo and in vitro, several lines of evidence converge on the following hypothesis: 'once a CNS neuron leaves the VZ, its cell cycle must be actively held in check. Relaxation of that vigilance leads to cell cycle initiation and death, which can follow within hours'.
Loose ends. At first glance Rb-deficient embryos seem to tell a simple story of failed cell cycle suppression leading quickly to cell death. However, it is not clear exactly how RB deficiency leads to neuron loss. First, the phenotype of these mice varies among brain regions, indicating that there is regional heterogeneity in RB dependence. Second, the lack of RB function in a neuron is not, by itself, sufficient to cause neuronal death. Rb−/− neurons can survive in the mixed environment of an Rb−/−↔Rb+/+ chimeric brain65,66,67, and conditional knockouts of Rb68,69also support this idea. This is not simply a near-neighbour effect, as the CNS phenotype is rescued in Rb−/−↔euploid Rb+/+; tetraploid chimeras69,70, in which Rb−/− embryos develop in a conceptus that includes wild-type (Rb+/+) extra-embryonic tissues. In the brains of the resulting animals, BrdU incorporation reveals that mutant nerve cells can begin a cell cycle but not die. Thus, failure of cell cycle suppression is not sufficient to lead to CRND by itself, although it might be necessary. Dissociation of the loss of cell cycle suppression from the process of neuronal death suggests a caveat to the final clause of the hypothesis — that death follows quickly after cycle initiation — a concept that is developed more fully by considering the situation in the adult brain.
Failure of cell cycle arrest in the adult
Our hypothesis predicts that the prohibition of neuronal cell division is life-long. Might examples of late-onset neurodegenerative disease be accompanied by loss of neuronal cell cycle control? This concept was first proposed to explain the presence of a unique species of phosphorylated tau protein, usually found only in dividing cells, in the neurons of patients who had died with Alzheimer's disease (AD)71,72. A number of laboratories have reported the re-expression of various cell cycle proteins in neurons from patients with AD. The proteins include cyclins A73, B73,74,75,76, D74,76,77,78 and E73,78, as well as CDKs71,77,79,80, PCNA73,74, Ki67 (Refs 73, 81 and CKIs of both the Ink and Cip/Kip families77,79,82,83. CDK1 may be particularly important in this group because of the tissue culture data mentioned previously63,64, and the recent evidence of genetic linkage to AD84,85. There are also reports of cell cycle protein re-expression in amyotrophic lateral sclerosis86,87,88, ataxia telangiectasia89, Parkinson's disease90,91,92,93, stroke94 and other neurodegenerative conditions95,96. Where quantification has been carried out, it seems that around 10% of at-risk neurons re-express these proteins.
These findings represent correlations between elevated protein expression levels and disease, not proof of CRND. In fact, if the immunocytochemistry is offering a correct picture, it seems likely that cell cycle proteins from different phases are co-expressed and that their location is frequently cytoplasmic. In this context, two studies75,76 are particularly noteworthy. One shows that cells that can be immunostained with antibodies to cell cycle proteins, when measured as a percentage of neurons in a region, are as prevalent during early stages of AD as they are during end-stage illness76. The other study investigated whether these proteins initiate a true cell cycle process, complete with DNA replication, by probing the interphase nuclei of neurons in the brains of patients with AD using fluorescent in situ hybridization (FISH) probes against unique genomic loci75. In at-risk regions of the brain, around 4% of the neurons had three or four spots of hybridization rather than two. Thus, the cell cycle protein expression in AD correlates with DNA replication, suggesting that at least the first phases of a true cell cycle have begun in the at-risk neurons. One clear implication of this is that in the adult, the presence of cell cycle proteins or even DNA replication on its own cannot be taken as evidence of adult neurogenesis. These events could easily represent the beginning of a cell death process with very much the opposite result.
Loose ends. Cell cycle regulation in the adult neuron is an area of study in which the number of loose ends vastly exceeds the clearly-established parts of the story. First, the cells never enter M phase. Condensed chromosomes are not found and there is no visible evidence of spindle formation. This makes it difficult to confidently characterize the process as a cell cycle as it is never completed. Second, where it has been quantified, there are too many cycling nerve cells74,75,76. The average course of AD is 10 years from first symptoms to death. If, as the immunostaining suggests, 5–10% of the neurons are dying at any one moment, and if a typical apoptotic process takes roughly 12 hours, then half of the affected population should be dead in a week or less and 95% should be dead in less than a month. This is clearly not the case. The implication is that death by cell cycle in adult neurons must be a very slow process requiring in the order of 6–12 months. Although this protracted time period is unexpected, mouse models of late onset human neurodegenerative diseases indicate that, if anything, 6–12 months might be an underestimate of the true length of the process as discussed in the next examples.
Transgenic mouse models of human inherited diseases, including ataxia telangiectasia97,98,99 and AD100,101,102,103,104,105,106, are noteworthy because, with few exceptions107, an otherwise excellent phenocopy falls short owing to the absence of neurodegeneration. The gene that is mutated in ataxia telangiectasia (Atm) signals the presence of DSBs and arrests the cell cycle to allow for DNA repair. In all reported mouse knockouts, the sterility, immune deficiency and radiosensitivity associated with the human condition are replicated faithfully, but their gross behaviour is normal and there is no detectable loss of Purkinje cells108. A similar effect is found in mouse models of AD: amyloid-β plaques appear along with behavioural abnormalities, but there is no apparent loss of neurons109. Remarkably, however, initiation of ectopic cell cycling is preserved. In Atm-knockout mice, cell cycle initiation can be found in Purkinje cells and striatal neurons89. Similarly, in the R1.40 yeast artificial chromosome transgenic line, an AD model, cycle anomalies begin at 6 months after birth in regions analogous to those in which the human disease begins, progressively appearing in the brainstem and cortical regions as in AD110. Two groups examined the APP23 mouse, another AD model, but disagreed on the presence of neuronal cell cycle events110,111. The difference may be in the age of the mice examined; however, the controversy remains unresolved. With the exception of this one report, a long delay between cell cycle initiation and cell death is apparent in these AD mice. Although R1.40 animals can live for two years after cell cycle events first appear, there is no apparent decrease in neuronal density and no documented loss of neurons.
The combined studies in humans and mice suggest a modification of the hypothesis articulated above. 'Once a CNS neuron leaves the VZ or SVZ, its cell cycle must be actively held in check. Relaxation of that vigilance leads to cell cycle initiation and death, which can follow within hours in newly generated neurons. Once neurons are fully mature, however, neuronal death by cycle re-initiation can take from months to years, and might require an additional stimulus to make the transition from cycle to death'.
This distinction between young and old neurons is illustrated in Fig. 3. The dashed arrows in this diagram reflect the possible need for an extra stimulus to trigger death in a cycling adult neuron.
What is a cell cycle protein?
Proteins identified as cell cycle proteins turn up in unlikely locations at unlikely times, to serve unlikely functions in nerve cells that, having left the VZ and SVZ, are supposed to have no further relationship with the cell cycle. One example of this is the Rb gene itself. Neurons of the embryonic Rb-deficient nervous system not only fail to survive, they also fail to differentiate20. That would appear to define an embryonic time during which the protein functions, but RB — along with its binding partner E2F1 — are both found in the cytoplasm and dendrites of the supposedly postmitotic neuron and both respond rapidly to exogenous stressors by changing their normally nuclear localization to a predominantly cytoplasmic one112,113,114. CKIs also have an important non-cycle role in differentiation115,116,117,118,119, which is independent of their role in cell cycle suppression117,119.
A further example of this cycle/differentiation duality is the 'atypical' cyclin-dependent kinase, CDK5 (Box 2). CDK5 has both pro-differentiation and anti-cell cycle activities during development120. In the adult, however, the kinase 'diversifies'. In many if not most CNS synapses, CDK5 forms complexes with121 and affects the function of 122,123,124,125,126,127various synaptic proteins.
Perhaps the most surprising example of the promiscuous function of cell cycle proteins is that members of the origin recognition complex (ORC) are found in synaptic fractions of adult neurons128. This is remarkable because the ORCs are a family of proteins best known for binding to specific sites in the genome during the process of mitotic DNA replication. The synaptic function of these proteins is unknown, although in other cell types they are reported to form complexes with proteins other than those of the ORC129.
Finally, a substantial fraction of neurons in the adult E2f1-knockout mouse are engaged in a strange cell cycle-like process (L. Wang and K.H., unpublished observations). They express high levels of cyclin A (cytoplasmic) and PCNA (nuclear), and by FISH criteria they have undergone DNA replication. Taken together, the data suggest that proteins best known for their role in cell cycle progression have separate functions in the fully differentiated, mitotically inactive neuron.
Are adult cycling neurons 'undead'?
As described above, neurons under stress can engage a cell-cycle-like process that leads to the constitutive expression of proteins normally found only in cycling cells and the acquisition of hyper-diploid DNA. Despite these oddities, cycling cells can persist in the brain for long periods. The dendrites of these neurons show only minimal atrophy89, but the behavioural anomalies found in the mouse models of both AD and ataxia telangiectasia hint at functional impairments. The question posed by this situation is: what is the nature of the state in which these nerve cells find themselves? Data from embryonic studies indicate that cell cycle initiation in a post-VZ neuron is a first step towards cell death. However, data from adult studies suggest that the processes of cell cycle initiation and cell death are separable. Similar situations, of neurons on a path to death being blocked by genetic or trophic means, have been reviewed recently for several species and have raised many important issues130.
Speculatively, it may be possible to draw an analogy between the arrested cell cycle state of these neurons and a cellular state defined in the imaginal discs of Drosophila melanogaster. The state was first proposed131 to describe cells that are triggered to die by an insult such as X-rays but blocked from completing the process by expression of an anti-apoptotic protein. The authors describe the resulting cells as 'undead' and have shown that they have some unusual properties131,132,133. For example, they send signals that serve as a mitogen to neighbouring cells. If the neighbouring cells are wild type, they divide in an apparent attempt to fill the gap in the tissue expected to be left by the dying cells.
Could the cycle-positive neurons in AD and ataxia telangiectasia brains be analogous to these undead cells, triggered to die but blocked from completing the process? If so, these cells might be part of the problem rather than innocent victims of the disease process. If in their undead state they are sending mitogenic signals to their neuronal neighbours, they could be pressuring otherwise healthy neurons to initiate a cell cycle (Fig. 4). If this is true, their stability and persistence could represent a danger to the health of the brain. As they do not die, their continued presence might weaken those around them and yet, because re-entry into a cell cycle does not seem to result in cell death, not kill them. This would create a paradox for those who seek therapeutic interventions for neurodegenerative conditions such as AD. The prediction would be that the most effective therapies would block new neurons from entering a cell cycle while simultaneously ridding the brain of the undead cells.
Conclusions and future directions
In many ways, descriptions of adult CNS neurons as having 'permanently exited the cell cycle' or having entered 'a permanent state of G0' are terms of convenience, which may lack true functional meaning. In fact, such terms might lull us into a false sense of security — a belief that the issue of cell cycle regulation in neurons is an oxymoron rather than an important biological question. We believe that the evidence reviewed here challenges us to rethink this position.
For billions of years, the prevailing entities (which ultimately became cells) were those that divided fastest and most efficiently. Metazoans evolved when aggregates of these early cells were able to realize gains from cooperation and specialization that exceeded those they could eke out by living on their own. It is worth considering that by this time the 'instinct' to divide was buried deep in the fundamental biology of every cell. It may even have preceded the emergence of a genome. Thus, the dividing instinct might be as powerful today as it was a billion years ago. The challenge faced by a metazoan, therefore, is to suppress the urge to cycle among its own constituents in order to enforce a regulated body plan and allow the extreme specialization (differentiation) of its members. Indeed, suppressing the cell cycle is arguably the most important step in any differentiation programme.
Neurons are among the most specialized of cells, and organisms that benefit from incorporating them into their structure seem to have largely solved the problem of reining in their drive to divide; the nature of the solution(s), however, remains largely unknown. But we may wish to rephrase questions such as what factors force a postmitotic neuron to re-enter a cell cycle in AD or what fail-safe mechanisms of cell cycle suppression are lost in AD such that pockets of neurons can break free of their postmitotic state and return to an earlier mode of existence. For neurons of the CNS it seems that anti-cycling kinases, cell cycle promoters turned into cell cycle suppressors, and DSBs during or immediately after the final cell division are all components of a strategy by which the metazoan developmental plan imposes cell cycle arrest on its neurons. This multi-tiered strategy involves not only changes in protein localization and altered biochemical networks, but perhaps rearrangements of DNA structure as well. The evolution of multicellular organisms appears to have been a stern mitotic master.
But evolution is also a miserly process. It tends to adapt old tools for new uses rather than fashion new tools. In neurons, this is reflected by the additional roles of cell cycle proteins such as E2F1, RB, CDKs, cyclins and ORC proteins in dendrites and axons. Under normal conditions these functions exemplify efficient design. Under stress, however, they appear to represent an Achilles' heel for the neuron. While some may start off as protective (for example, p27 and CDK5), many can be dangerous to the health of the cell if they end up in the wrong cellular location.
If cell cycle regulation is truly a constant issue for an adult neuron then an entire menu of action items seems spread before us. One important initiative would be to drop, whenever possible, the reference to proteins as cell cycle proteins. Each protein whose first known function was to advance or retard the progression of the cell cycle appears to have alternative identities in neurons and other differentiated cells. Restricting our focus to their role in cell cycle regulation may blind us to the full repertoire of their activities. We also need to remind ourselves that the mechanics of cell cycle regulation can be distinct in different cell types. Textbooks tell us that the E2F1 protein drives the cell cycle by upregulating the synthesis of key proteins needed for cell cycle progression, as is indeed the case in cultured fibroblasts and COS cells; however, E2f1-knockout animals are born and develop normally, but die in middle age with tumours and hyperplasias in a variety of exocrine tissues134,135. Clearly, in some cells E2F1 functions as a tumour suppressor. Finally, it seems apparent that, just as in real estate, the three keys to activity are location, location and location. We need to define where these multifunctional proteins are in neurons at different junctures of the developmental process and during the response to insult or injury. The behaviour of CDK5 in CRND suggests that its function in the nucleus is different from that in the cytoplasm. This is not a new insight, but it is part of a readjustment to the notion that we can avoid concerning ourselves with the regulation of the cell cycle in all highly differentiated cells — especially neurons. Indeed, to reach a fuller understanding of how neurons remain mitotically silent for decades, there is a great deal of new biology yet to learn.
References
Cai, L., Hayes, N. L. & Nowakowski, R. S. Synchrony of clonal cell proliferation and contiguity of clonally related cells: production of mosaicism in the ventricular zone of developing mouse neocortex. J. Neurosci. 17, 2088–2100 (1997).
Cai, L., Hayes, N. L. & Nowakowski, R. S. Local homogeneity of cell cycle length in developing mouse cortex. J. Neurosci. 17, 2079–2087 (1997).
Takahashi, T., Goto, T., Miyama, S., Nowakowski, R. S. & Caviness, V. S. Jr. Sequence of neuron origin and neocortical laminar fate: relation to cell cycle of origin in the developing murine cerebral wall. J. Neurosci. 19, 10357–10371 (1999).
Takahashi, T., Nowakowski, R. S. & Caviness, V. S. Jr. The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall. J. Neurosci. 15, 6046–6057 (1995).
Takahashi, T., Nowakowski, R. S. & Caviness, V. S. Jr. Cell cycle parameters and patterns of nuclear movement in the neocortical proliferative zone of the fetal mouse. J. Neurosci. 13, 820–833 (1993).
Miale, I. L. & Sidman, R. L. An autoradiographic analysis of histogenesis in the mouse cerebellum. Exp. Neurol. 4, 277–296 (1961).
Uzman, L. L. The histogenesis of the mouse cerebellum as studied by its tritiated thymidine uptake. J. Comp. Neurol. 114, 137–159 (1960).
Nowakowski, R. S., Lewin, S. B. & Miller, M. W. Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population. J. Neurocyt. 18, 311–318 (1989).
Bonnert, T. P. et al. Molecular characterization of adult mouse subventricular zone progenitor cells during the onset of differentiation. Eur. J. Neurosci. 24, 661–675 (2006).
Noctor, S. C., Martinez-Cerdeno, V., Ivic, L. & Kriegstein, A. R. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nature Neurosci. 7, 136–144 (2004).
Taupin, P. Neurogenesis in the adult central nervous system. C. R. Biol. 329, 465–475 (2006).
Sohur, U. S., Emsley, J. G., Mitchell, B. D. & Macklis, J. D. Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361, 1477–1497 (2006).
Aimone, J. B., Wiles, J. & Gage, F. H. Potential role for adult neurogenesis in the encoding of time in new memories. Nature Neurosci. 9, 723–727 (2006).
Kuan, C. Y. et al. Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J. Neurosci. 24, 10763–10772 (2004).
Kenney, A. M., Cole, M. D. & Rowitch, D. H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130, 15–28 (2003).
Ruiz i Altaba, A., Palma, V. & Dahmane, N. Hedgehog–Gli signalling and the growth of the brain. Nature Rev. Neurosci. 3, 24–33 (2002).
Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328–330 (1992).
Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288–294 (1992).
Lee, E. Y. et al. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8, 2008–2021 (1994). A detailed description of how a cell cycle protein can also be a potent pro-differentiation agent.
Cunningham, J. J. & Roussel, M. F. Cyclin-dependent kinase inhibitors in the development of the central nervous system. Cell Growth Differ. 12, 387–396 (2001).
Cunningham, J. J. et al. The cyclin-dependent kinase inhibitors p19Ink4d and p27Kip1 are coexpressed in select retinal cells and act cooperatively to control cell cycle exit. Mol. Cell. Neurosci. 19, 359–374 (2002). A clear demonstration of how certain CKIs assist in the orderly cessation of neuronal cell division.
Schmetsdorf, S., Gartner, U. & Arendt, T. Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int. J. Dev. Neurosci. 23, 101–112 (2005).
Blackshaw, S. et al. Genomic analysis of mouse retinal development. PLoS Biol. 2, E247 (2004).
Dehay, C., Savatier, P., Cortay, V. & Kennedy, H. Cell-cycle kinetics of neocortical precursors are influenced by embryonic thalamic axons. J. Neurosci. 21, 201–214 (2001).
Lukaszewicz, A. et al. G1 phase regulation, area-specific cell cycle control, and cytoarchitectonics in the primate cortex. Neuron 47, 353–364 (2005).
Gao, Y. et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95, 891–902 (1998).
Barnes, D. E., Stamp, G., Rosewell, I., Denzel, A. & Lindahl, T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8, 1395–1398 (1998).
Esposito, G. et al. Mice reconstituted with DNA polymerase β-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their Ig genes normally. Proc. Natl Acad. Sci. USA 97, 1166–1171 (2000).
Sugo, N., Aratani, Y., Nagashima, Y., Kubota, Y. & Koyama, H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase β. EMBO J. 19, 1397–1404 (2000).
Lee, Y., Barnes, D. E., Lindahl, T. & McKinnon, P. J. Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. Genes Dev. 14, 2576–2580 (2000).
Chun, J. Cell death, DNA breaks and possible rearrangements: an alternative view. Trends Neurosci. 23, 407–409 (2000).
Gilmore, E. C., Herrup, K., Nowakowski, R. S. & Caviness, V. S. Jr. Reply. Trends Neurosci. 23, 408–409 (2000).
Gilmore, E. C., Nowakowski, R. S., Caviness, V. S. Jr. & Herrup, K. Cell birth, cell death, cell diversity and DNA breaks: how do they all fit together? Trends Neurosci. 23, 100–105 (2000).
Baker, S. J. & McKinnon, P. J. Tumour-suppressor function in the nervous system. Nature Rev. Cancer 4, 184–196 (2004).
O'Driscoll, M. & Jeggo, P. A. The role of double-strand break repair- insights from human genetics. Nature Rev. Genet. 7, 45–54 (2006).
Murphy, M. et al. Delayed early embryonic lethality following disruption of the murine cyclin A2 gene. Nature Genet. 15, 83–86 (1997).
Brandeis, M. et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc. Natl Acad. Sci. USA 95, 4344–4349 (1998).
Kozar, K. et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118, 477–491 (2004).
Levine, E. M., Close, J., Fero, M., Ostrovsky, A. & Reh, T. A. p27Kip1 regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299–314 (2000).
Mitsuhashi, T. et al. Overexpression of p27Kip1 lengthens the G1 phase in a mouse model that targets inducible gene expression to central nervous system progenitor cells. Proc. Natl Acad. Sci. USA 98, 6435–6440 (2001).
Ciemerych, M. A. & Sicinski, P. Cell cycle in mouse development. Oncogene 24, 2877–2898 (2005). This is a comprehensive yet readable overview of virtually every cell cycle gene knockout in mice.
al-Ubaidi, M. R., Hollyfield, J. G., Overbeek, P. A. & Baehr, W. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc. Natl Acad. Sci. USA 89, 1194–1198 (1992).
Feddersen, R. M., Clark, H. B., Yunis, W. S. & Orr, H. T. In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Mol. Cell. Neurosci. 6, 153–167 (1995).
Feddersen, R. M., Ehlenfeldt, R., Yunis, W. S., Clark, H. B. & Orr, H. T. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron 9, 955–966 (1992). The earliest demonstration (see also references 44 and 46) that driving a cell cycle in a postmitotic neuron triggers death rather than division.
Feddersen, R. M. et al. Susceptibility to cell death induced by mutant SV40 T-antigen correlates with Purkinje neuron functional development. Mol. Cell. Neurosci. 9, 42–62 (1997).
Athanasiou, M. C. et al. The transcription factor E2F-1 in SV40 T antigen-induced cerebellar Purkinje cell degeneration. Mol. Cell. Neurosci. 12, 16–28 (1998).
Macleod, K. F., Hu, Y. & Jacks, T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15, 6178–6188 (1996).
Tsai, K. Y. et al. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell 2, 293–304 (1998).
Freeman, R. S., Estus, S. & Johnson, E. M. Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 12, 343–355 (1994).
Herrup, K. & Busser, J. C. The induction of multiple cell cycle events precedes target-related neuronal death. Development 121, 2385–2395 (1995). The first demonstration that natural examples of developmental cell death are preceded by cell cycle activation.
Farinelli, S. E. & Greene, L. A. Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support. J. Neurosci. 16, 1150–1162 (1996).
Park, D. S., Levine, B., Ferrari, G. & Greene, L. A. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17, 8975–8983 (1997).
Park, D. S., Morris, E. J., Greene, L. A. & Geller, H. M. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17, 1256–1270 (1997).
Park, D. S., Farinelli, S. E. & Greene, L. A. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271, 8161–8169 (1996).
Ferrari, G. & Greene, L. A. Proliferative inhibition by dominant-negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. EMBO J. 13, 5922–5928 (1994).
Park, D. S., Obeidat, A., Giovanni, A. & Greene, L. A. Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol. Aging 21, 771–781 (2000).
Courtney, M. J. & Coffey, E. T. The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons. Eur. J. Neurosci. 11, 1073–1084 (1999).
Mirjany, M., Ho, L. & Pasinetti, G. M. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J. Pharmacol. Exp. Ther. 301, 494–500 (2002).
Padmanabhan, J., Park, D. S., Greene, L. A. & Shelanski, M. L. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J. Neurosci. 19, 8747–8756 (1999).
Liu, D. X., Biswas, S. C. & Greene, L. A. B-myb and C-myb play required roles in neuronal apoptosis evoked by nerve growth factor deprivation and DNA damage. J. Neurosci. 24, 8720–8725 (2004).
Biswas, S. C., Liu, D. X. & Greene, L. A. Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J. Neurosci. 25, 8349–8358 (2005).
Konishi, Y. & Bonni, A. The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J. Neurosci. 23, 1649–1658 (2003).
Konishi, Y., Lehtinen, M., Donovan, N. & Bonni, A. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell 9, 1005–1016 (2002).
Lipinski, M. M. et al. Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. EMBO J. 20, 3402–3413 (2001).
Maandag, E. C. et al. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13, 4260–4268 (1994).
Williams, B. O. et al. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13, 4251–4259 (1994).
MacPherson, D. et al. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol. Cell Biol. 23, 1044–1053 (2003).
Wu, L. et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421, 942–947 (2003).
De Bruin, A. et al. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc. Natl Acad. Sci. USA 100, 6546–6551 (2003).
Vincent, I., Rosado, M. & Davies, P. Mitotic mechanisms in Alzheimer's disease? J. Cell Biol. 132, 413–425 (1996).
Vincent, I., Zheng, J. H., Dickson, D. W., Kress, Y. & Davies, P. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol. Aging 19, 287–296 (1998).
Nagy, Z., Esiri, M., Cato, A. & Smith, A. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. (Berl) 94, 6–15 (1997).
Busser, J., Geldmacher, D. S. & Herrup, K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18, 2801–2807 (1998). The first demonstration that cell cycle events in human neurodegenerative disease are accompanied by DNA replication.
Yang, Y., Geldmacher, D. S. & Herrup, K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21, 2661–2668 (2001).
Yang, Y., Mufson, E. J. & Herrup, K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 23, 2557–2563 (2003).
Arendt, T., Holzer, M. & Gartner, U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J. Neural Transm. 105, 949–960 (1998).
Hoozemans, J. J. et al. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J. Neuropathol. Exp. Neurol. 61, 678–688 (2002).
McShea, A., Harris, P. L., Webster, K. R., Wahl, A. F. & Smith, M. A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150, 1933–1939 (1997).
Vincent, I., Jicha, G., Rosado, M. & Dickson, D. W. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588–3598 (1997).
Smith, M. Z., Nagy, Z. & Esiri, M. M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci. Lett. 271, 45–48 (1999).
Arendt, T., Rodel, L., Gartner, U. & Holzer, M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7, 3047–3049 (1996).
Zhu, X. et al. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J. Neurosci. Res. 75, 698–703 (2004).
Johansson, A. et al. Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 20, 367–374 (2005).
Johansson, A. et al. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci. Lett. 340, 69–73 (2003).
Nguyen, M. D. et al. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J. Neurosci. 23, 2131–2140 (2003).
Ranganathan, S. & Bowser, R. Alterations in G1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 162, 823–835 (2003).
Ranganathan, S., Scudiere, S. & Bowser, R. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J. Alzheimers Dis. 3, 377–385 (2001).
Yang, Y. & Herrup, K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J. Neurosci. 25, 2522–2529 (2005).
Burns, K. A. et al. Nestin-CreER mice reveal DNA synthesis by nonapoptotic neurons following cerebral ischemia-hypoxia. Cereb. Cortex 27 Jan 2007 (doi:10.1093/cercor/bhl164).
Höglinger, G. et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc. Natl Acad. Sci. USA 104, 3585–3590 (2007).
Jordan-Sciutto, K. L., Dorsey, R., Chalovich, E. M., Hammond, R. R. & Achim, C. L. Expression patterns of retinoblastoma protein in Parkinson disease. J. Neuropathol. Exp. Neurol. 62, 68–74 (2003).
West, A. B., Dawson, V. L. & Dawson, T. M. To die or grow: Parkinson's disease and cancer. Trends Neurosci. 28, 348–352 (2005).
Love, S. Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neurosci. Lett. 353, 29–32 (2003).
Jordan-Sciutto, K. L., Wang, G., Murphey-Corb, M. & Wiley, C. A. Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. J. Neurosci. 22, 2185–2195 (2002).
Jordan-Sciutto, K. L., Wang, G., Murphy-Corb, M. & Wiley, C. A. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis. Am. J. Pathol. 157, 497–507 (2000).
Barlow, C. et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996).
Borghesani, P. R. et al. Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice. Proc. Natl Acad. Sci. USA 97, 3336–3341 (2000).
Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996).
Lamb, B. T. et al. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nature Genet. 5, 22–30 (1993).
Hsiao, K. K. et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203–1218 (1995).
Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl Acad. Sci. USA 94, 13287–13292 (1997).
Mucke, L. et al. High-level neuronal expression of aβ 1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).
Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72 (1997).
Calhoun, M. E. et al. Neuron loss in APP transgenic mice. Nature 395, 755–756 (1998).
Barlow, C. et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl Acad. Sci. USA 97, 871–876 (2000).
Hock, B. J. Jr. & Lamb, B. T. Transgenic mouse models of Alzheimer's disease. Trends Genet. 17, S7–S12 (2001).
Yang, Y., Varvel, N. H., Lamb, B. T. & Herrup, K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J. Neurosci. 26, 775–784 (2006).
Gartner, U. et al. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. Acta Neuropathol. (Berl) 106, 535–544 (2003).
Jordan-Sciutto, K., Rhodes, J. & Bowser, R. Altered subcellular distribution of transcriptional regulators in response to Aβ peptide and during Alzheimer's disease. Mech. Ageing Dev. 123, 11–20 (2001).
Jordan-Sciutto, K. L., Murray Fenner, B. A., Wiley, C. A. & Achim, C. L. Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp. Neurol. 167, 205–214 (2001).
Strachan, G. D., Kopp, A. S., Koike, M. A., Morgan, K. L. & Jordan-Sciutto, K. L. Chemokine- and neurotrophic factor-induced changes in E2F1 localization and phosphorylation of the retinoblastoma susceptibility gene product (pRb) occur by distinct mechanisms in murine cortical cultures. Exp. Neurol. 193, 455–468 (2005).
Delalle, I., Takahashi, T., Nowakowski, R. S., Tsai, L. H. & Caviness, V. S. Jr. Cyclin E-p27 opposition and regulation of the G1 phase of the cell cycle in the murine neocortical PVE: a quantitative analysis of mRNA in situ hybridization. Cereb. Cortex 9, 824–832 (1999). A detailed look at the effects on cell cycle kinetics of the elimination of a key CDK inhibitor, p27.
Dyer, M. A. & Cepko, C. L. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J. Neurosci. 21, 4259–4271 (2001).
Dyer, M. A. & Cepko, C. L. p57Kip2 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127, 3593–3605 (2000).
Gui, H., Li, S. & Matise, M. P. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord. Dev. Biol. 301, 14–26 (2007).
Nguyen, L. et al. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev. 20, 1511–1524 (2006).
Cicero, S. & Herrup, K. Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J. Neurosci. 25, 9658–9668 (2005).
Rosales, J. L., Nodwell, M. J., Johnston, R. N. & Lee, K. Y. Cdk5/p25nck5a interaction with synaptic proteins in bovine brain. J. Cell Biochem. 78, 151–159 (2000).
Fu, A. K. et al. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nature Neurosci. 4, 374–381 (2001).
Fu, A. K. et al. Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc. Natl Acad. Sci. USA 102, 15224–15229 (2005).
Fu, W. Y. et al. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nature Neurosci. 10, 67–76 (2007).
Lee, S. Y., Wenk, M. R., Kim, Y., Nairn, A. C. & De Camilli, P. Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl Acad. Sci. USA 101, 546–551 (2004).
Morabito, M. A., Sheng, M. & Tsai, L. H. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 24, 865–876 (2004).
Tomizawa, K. et al. Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell Biol. 163, 813–824 (2003).
Huang, Z., Zang, K. & Reichardt, L. F. The origin recognition core complex regulates dendrite and spine development in postmitotic neurons. J. Cell Biol. 170, 527–535 (2005). Analysis of the unexplained presence of proteins normally associated with DNA replication biochemistry in the mature neuronal synapse.
Thome, K. C. et al. Subsets of human origin recognition complex (ORC) subunits are expressed in non-proliferating cells and associate with non-ORC proteins. J. Biol. Chem. 275, 35233–35241 (2000).
Buss, R. R. & Oppenheim, R. W. Role of programmed cell death in normal neuronal development and function. Anat. Sci. Int. 79, 191–197 (2004).
Perez-Garijo, A., Martin, F. A. & Morata, G. Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila. Development 131, 5591–5598 (2004). 'Undead' cells signal with mitogens to neighbouring cells; the authors take a first pass at identifying the signalling molecules involved.
Perez-Garijo, A., Martin, F. A., Struhl, G. & Morata, G. Dpp signaling and the induction of neoplastic tumors by caspase-inhibited apoptotic cells in Drosophila. Proc. Natl Acad. Sci. USA 102, 17664–17669 (2005).
Huh, J. R., Guo, M. & Hay, B. A. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr. Biol. 14, 1262–1266 (2004).
Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549–561 (1996).
Yamasaki, L. et al. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85, 537–548 (1996).
McKinnon, P. J. ATM and ataxia telangiectasia. EMBO Rep. 5, 772–776 (2004).
Shiloh, Y. & Kastan, M. B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83, 209–254 (2001).
Kastan, M. B. & Lim, D. S. The many substrates and functions of ATM. Nature Rev. Mol. Cell Biol. 1, 179–186 (2000).
Gilmore, E. C., Ohshima, T., Goffinet, A. M., Kulkarni, A. B. & Herrup, K. Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J. Neurosci. 18, 6370–6377 (1998).
Ohshima, T. et al. Migration defects of cdk5−/− neurons in the developing cerebellum is cell autonomous. J. Neurosci. 19, 6017–6026 (1999).
Ohshima, T. et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11173–11178 (1996).
O'Hare, M. J. et al. Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25, 8954–8966 (2005).
Fantl, V., Stamp, G., Andrews, A., Rosewell, I. & Dickson, C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364–2372 (1995).
Sicinski, P. et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621–630 (1995).
Sicinski, P. et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384, 470–474 (1996).
Huard, J. M., Forster, C. C., Carter, M. L., Sicinski, P. & Ross, M. E. Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development 126, 1927–1935 (1999).
Georgia, S. & Bhushan, A. β cell replication is the primary mechanism for maintaining postnatal β cell mass. J. Clin. Invest. 114, 963–968 (2004).
Ciemerych, M. A. et al. Development of mice expressing a single D-type cyclin. Genes Dev. 16, 3277–3289 (2002).
Lee, M. H. et al. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10, 1621–1632 (1996).
Eilam, R. et al. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc. Natl Acad. Sci. USA 95, 12653–12656 (1998).
Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397–402 (2000).
Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev. 14, 1448–1459 (2000).
Takai, H. et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21, 5195–5205 (2002).
Acknowledgements
This work was supported by the National Institutes of Health, the A–T Children's Project, the Alzheimer's Association and the Coins for Alzheimer's Research Trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Related links
DATABASES
OMIM
Glossary
- Neuronal birthday
-
The day on which a neuron exits mitosis and differentiates rather than re-enter a new cell cycle. Defined operationally as the last day that the adult neuron can be labelled by exogenously applied 5-bromo-2′-deoxyuridine.
- Cytokinesis
-
The process of physically dividing the nuclear and cytoplasmic components of a cell in M phase into two daughter cells.
- Phosphohistone H3
-
A phosphorylated form of the DNA coating protein, histone H3. Empirically, the presence of this modification is unique to M phase.
- Proliferating cell nuclear antigen
-
(PCNA). A subunit of the DNA replication complex. Three PCNA proteins assemble as a homo-trimer encircling the double helix just ahead of the replication fork.
- Ligase IV
-
A form of DNA ligase that rejoins 5′ and 3′ ends of apposed double-strands of DNA. This ligase isoform is specific for DNA repair, especially non-homologous end joining.
- Transformed
-
A cellular state marked by escape from growth control mechanisms that normally regulate the cell cycle. Typically, transformed cells will form tumours in soft agar and in animals.
- PC12 cells
-
A rat pheochromocytoma cell line. When treated with nerve growth factor, PC12 cells cease mitosis and differentiate into cells that resemble sympathetic neurons, complete with processes and functional synapses.
- Mitogen
-
A substance, usually a protein, that induces cell division in a receptive cell.
Rights and permissions
About this article
Cite this article
Herrup, K., Yang, Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat Rev Neurosci 8, 368–378 (2007). https://doi.org/10.1038/nrn2124
Issue Date:
DOI: https://doi.org/10.1038/nrn2124
This article is cited by
-
Prion disease modelled in Drosophila
Cell and Tissue Research (2023)
-
Survival of compromised adult sensory neurons involves macrovesicular formation
Cell Death Discovery (2022)
-
Aβ-induced mitochondrial dysfunction in neural progenitors controls KDM5A to influence neuronal differentiation
Experimental & Molecular Medicine (2022)
-
Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
Alzheimer's Research & Therapy (2021)
-
Obesity-linked circular RNA circTshz2-2 regulates the neuronal cell cycle and spatial memory in the brain
Molecular Psychiatry (2021)